Considering the vasodilatory and proliferative effects of EtbR, the increased expression of ErbR in Trpc3−/− hearts under conditions of CIH may be a compensatory response of the heart to pulmonary hypertension resulting from impaired NO secretion [10]. Here, TRPC3 is linked to pulmonary arterial hypertension.